Russian Pharmaceutical Forum is the foremost gathering of CEOs of international and local pharmaceutical producers, distributors and retailers. BIC Securities supported the event for the second consecutive year.
Aleksandr Lobakov, Head of Healthcare and Pharmaceuticals Practice at BIC Securities, shared his views on the subject of “Latest trends in pharmaceutical mergers and acquisitions (M&A) space in Russia" and covered the following areas:
▪ Overview of key recent M&A transactions in the region
▪ Rationales for M&A from investors and local companies’ side
▪ Varying views of investors and local companies’ shareholders towards structuring of M&A deals
▪ Case study of “Akvion”/”Recordati” deal as an example of successfully structured and implemented transaction
Event interview with Aleksandr Lobakov can be found at the following link: http://www.adamsmithconferences.com/event/pharma-industry-russia/eventtv/ch/20564294/v/MWqX0JeZ0ns
Return to archive